Vyacheslav A. Chubenko

Saint Petersburg, SPE, Russian Federation

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

Distinct pathways of disease progression with dual checkpoint blockade versus immunotargeted therapy in metastatic renal cell carcinoma.

Distinct pathways of disease progression with dual checkpoint blockade versus immunotargeted therapy in metastatic renal cell carcinoma.

Journal: Urologic oncology

Published: September 01, 2025

Real-World Efficacy and Safety of Avelumab Plus Axitinib in Metastatic Renal Cell Carcinoma: Results from the Ambispective RAVE-Renal Study.

Real-World Efficacy and Safety of Avelumab Plus Axitinib in Metastatic Renal Cell Carcinoma: Results from the Ambispective RAVE-Renal Study.

Journal: Current oncology (Toronto, Ont.)

Published: November 19, 2024

Minimal PK/PD model for simultaneous description of the maximal tolerated dose and metronomic treatment outcomes in mouse tumor models.

Minimal PK/PD model for simultaneous description of the maximal tolerated dose and metronomic treatment outcomes in mouse tumor models.

Journal: Cancer chemotherapy and pharmacology

Published: February 04, 2021

"Lazarus Response" to Olaparib in a Virtually Chemonaive Breast Cancer Patient Carrying Gross BRCA2 Gene Deletion.

"Lazarus Response" to Olaparib in a Virtually Chemonaive Breast Cancer Patient Carrying Gross BRCA2 Gene Deletion.

Journal: Cureus

Published: April 14, 2018

First-Line Cetuximab Monotherapy in KRAS/NRAS/BRAF Mutation-Negative Colorectal Cancer Patients.

First-Line Cetuximab Monotherapy in KRAS/NRAS/BRAF Mutation-Negative Colorectal Cancer Patients.

Journal: Clinical drug investigation

Published: February 23, 2018

Survival Outcomes in EGFR Mutation-Positive Lung Cancer Patients Treated with Gefitinib until or beyond Progression.

Survival Outcomes in EGFR Mutation-Positive Lung Cancer Patients Treated with Gefitinib until or beyond Progression.

Journal: Oncology research and treatment

Published: March 29, 2016

Experience with the use of gefitinib in patients with inoperable non-squamous cell lung cancer with activating EGFR mutations

Experience with the use of gefitinib in patients with inoperable non-squamous cell lung cancer with activating EGFR mutations

Journal: Voprosy onkologii

Published: June 20, 2015

Therapeutic activity of gemcitabine in intracranial tumors

Therapeutic activity of gemcitabine in intracranial tumors

Journal: Voprosy onkologii

Published: June 20, 2015

High efficacy of cisplatin neoadjuvant therapy in a prospective series of patients carrying BRCA1 germ-line mutation.

High efficacy of cisplatin neoadjuvant therapy in a prospective series of patients carrying BRCA1 germ-line mutation.

Journal: Medical oncology (Northwood, London, England)

Published: January 08, 2015

Evidence for clinical efficacy of mitomycin C in heavily pretreated ovarian cancer patients carrying germ-line BRCA1 mutation.

Evidence for clinical efficacy of mitomycin C in heavily pretreated ovarian cancer patients carrying germ-line BRCA1 mutation.

Journal: Medical oncology (Northwood, London, England)

Published: August 07, 2014

Markers of effectiveness of preoperative taxane-based chemotherapy for locally advanced breast cancer

Markers of effectiveness of preoperative taxane-based chemotherapy for locally advanced breast cancer

Journal: Voprosy onkologii

Published: August 06, 2013

Gene expression analysis and its clinical use in breast tumors

Gene expression analysis and its clinical use in breast tumors

Journal: Voprosy onkologii

Published: June 29, 2013

Showing 1-12 of 12

Last Updated: 09/26/2026